Terms: = Liver cancer AND WIF1, WIF-1, 11197, ENSG00000156076
18 results:
1. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating wif1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R
BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955
[TBL] [Abstract] [Full Text] [Related]
2. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating wif1.
Li C; Wang Z; Chen S; Zhang J; Qu K; Liu C
Int J Mol Med; 2018 Dec; 42(6):3309-3317. PubMed ID: 30221686
[TBL] [Abstract] [Full Text] [Related]
4. Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in liver cancer Cell Lines.
Uribe D; Cardona A; Esposti DD; Cros MP; Cuenin C; Herceg Z; Camargo M; Cortés-Mancera FM
Ann Hepatol; 2018; 17(3):444-460. PubMed ID: 29735783
[TBL] [Abstract] [Full Text] [Related]
5. RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.
Bachet JB; Bouché O; Taieb J; Dubreuil O; Garcia ML; Meurisse A; Normand C; Gornet JM; Artru P; Louafi S; Bonnetain F; Thirot-Bidault A; Baumgaertner I; Coriat R; Tougeron D; Lecomte T; Mary F; Aparicio T; Marthey L; Taly V; Blons H; Vernerey D; Laurent-Puig P
Ann Oncol; 2018 May; 29(5):1211-1219. PubMed ID: 29438522
[TBL] [Abstract] [Full Text] [Related]
6. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract] [Full Text] [Related]
7. Helicobacter pylori-induced modulation of the promoter methylation of Wnt antagonist genes in gastric carcinogenesis.
Yang HJ; Kim SG; Lim JH; Choi JM; Kim WH; Jung HC
Gastric Cancer; 2018 Mar; 21(2):237-248. PubMed ID: 28643146
[TBL] [Abstract] [Full Text] [Related]
8. Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.
Zhang C; Li J; Huang T; Duan S; Dai D; Jiang D; Sui X; Li D; Chen Y; Ding F; Huang C; Chen G; Wang K
Oncotarget; 2016 Dec; 7(49):81255-81267. PubMed ID: 27835605
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of hepatocellular carcinoma by fulvestrant involves the estrogen receptor α and Wnt pathways in vitro and in patients.
Wang CJ; Guo DK; You TG; Shen DW; Wang C; Tang L; Wang J; Xu RH; Zhang H
Mol Med Rep; 2014 Dec; 10(6):3125-31. PubMed ID: 25270093
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor wif-1.
Ji D; Chen Z; Li M; Zhan T; Yao Y; Zhang Z; Xi J; Yan L; Gu J
Mol Cancer; 2014 Apr; 13():86. PubMed ID: 24755295
[TBL] [Abstract] [Full Text] [Related]
11. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
Kaur P; Mani S; Cros MP; Scoazec JY; Chemin I; Hainaut P; Herceg Z
Tumour Biol; 2012 Apr; 33(2):325-36. PubMed ID: 22351518
[TBL] [Abstract] [Full Text] [Related]
13. CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis.
Liu JB; Zhang YX; Zhou SH; Shi MX; Cai J; Liu Y; Chen KP; Qiang FL
World J Gastroenterol; 2011 Nov; 17(42):4718-24. PubMed ID: 22180715
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation.
Huang L; Li MX; Wang L; Li BK; Chen GH; He LR; Xu L; Yuan YF
Tumour Biol; 2011 Feb; 32(1):233-40. PubMed ID: 21052890
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic silencing of wif-1 in hepatocellular carcinomas.
Deng Y; Yu B; Cheng Q; Jin J; You H; Ke R; Tang N; Shen Q; Shu H; Yao G; Zhang Z; Qin W
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1161-7. PubMed ID: 20119713
[TBL] [Abstract] [Full Text] [Related]
16. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract] [Full Text] [Related]
17. Promoter methylation and mRNA expression of DKK-3 and wif-1 in hepatocellular carcinoma.
Ding Z; Qian YB; Zhu LX; Xiong QR
World J Gastroenterol; 2009 Jun; 15(21):2595-601. PubMed ID: 19496188
[TBL] [Abstract] [Full Text] [Related]
18. Comparative genomics on SFRP1 orthologs.
Katoh Y; Katoh M
Int J Oncol; 2005 Sep; 27(3):861-5. PubMed ID: 16077939
[TBL] [Abstract] [Full Text] [Related]
